Long-term effectiveness of a new ฮฑ-gluco
โ
Mitrakou, A.; Tountas, N.; Raptis, A.E.; Bauer, R.J.; Schulz, H.; Raptis, S.A.
๐
Article
๐
1998
๐
John Wiley and Sons
๐
English
โ 83 KB
๐ 1 views
In a double-blind, randomized study, miglitol (BAY m 1099), an โฃ-glucosidase inhibitor, 100 mg tds or placebo was given orally with meals for a period of 24 weeks in 117 patients with Type 2 (non-insulin-dependent) diabetes mellitus (DM) treated with insulin. Fasting and 1 h postprandial plasma gluc